SEC Form 4 · accession 0001387131-17-003409
TherapeuticsMD, Inc. · TXMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tommy G Thompson
Director
Period of report
Jun 21, 2017
Accepted (ET)
Jun 23, 2017 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000025743
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $5.80 | Jun 21, 2017 | A | 75,000 | A | Jun 21, 2018 | Jun 21, 2027 | Common Stock | 75,000 | 75,000 | D |